Should You Buy Salesforce Stock Before the Huge Investor Update? | CRM Stock Analysis

Parkev analyzes Salesforce ahead of its upcoming earnings report, weighing the company's historical growth against its current decelerating revenue trends. Parkev notes that while Salesforce grew revenue significantly over the last decade, growth has now slowed to near double digits and is projected to fall into the 9% range by 2028. Parkev highlights the threat of 'agentic AI,' which is causing some enterprises to pause spending or consider building proprietary alternatives to Salesforce’s CRM tools.

Despite these growth concerns, Parkev emphasizes the company's internal operational success following a major 2022 restructuring. Parkev points out that operating margins have surged from historically low levels to a record 21.87%, while returns on invested capital have also reached new highs of 10.81%. Parkev suggests that the company is functioning better than ever internally, even if external market dynamics are challenging.

Regarding valuation, Parkev identifies the current forward P/E of 12.7 as being remarkably low, suggesting the market is pricing Salesforce as a business in terminal decline. Parkev has revised the intrinsic fair value estimate down to $265 per share due to slower growth expectations. However, with the stock trading around $198, Parkev concludes that the risk versus reward favor investors.